On April 1, 2020, Medifron DBT Co., Ltd. (KOSDAQ:A065650) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,600 KRW | -0.65% | -1.08% | -7.07% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,625 KRW | +0.96% | +2.74% | 95.9M | ||
1,502 KRW | +1.76% | +1.49% | 68.72M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.07% | 194M | |
+14.58% | 70.29B | |
+6.71% | 17.8B | |
+23.57% | 13.68B | |
+7.64% | 13.15B | |
+19.52% | 10.13B | |
-24.66% | 6.51B | |
-6.71% | 5.86B | |
+0.31% | 5.14B | |
-0.13% | 4.99B |
- Stock Market
- Equities
- A204620 Stock
- News Global Tax Free Co., Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 10.999996728 billion in funding from Brain Contents CO., LTD., Swanicoco Co., Ltd., Global Tax Free Co., Ltd.